01. February 2012
Roche in 2011: Strong results and positive outlook
Group sales rise 2% 1 (-10% in Swiss francs; +6% in US dollars), excluding Tamiflu; Significant foreign exchange impact of –12 percentage points due to appreciation of the Swiss franc; overall Group sales at 42.5 billion Swiss francs. more
Media: News and Press Releases
Media Releases
- February 01, 2012
Roche in 2011: Strong results and positive outlook - January 31, 2012
Roche to nominate slate of independent directors for election at Illumina, Inc.'s 2012 annual meeting - January 30, 2012
FDA approves Erivedge (vismodegib) capsule, the first medicine for adults with advanced basal cell carcinoma
Roche in the Media
|
August 31, 2011 Roche to maintain lead in targeted drugs Roche expects a new generation of drugs targeted at specific groups of patients to make up half its portfolio in 10 years, a shift that is pushing the boundaries of modern medicine. (Reuters.com) |
|
August 22, 2011 A healthy forecast for pharma Dow Jones Interview with Severin Schwan |
Services
- Contacts
- Media Archive
- Medialibrary
- Download Corporate Brochures
- RSS-Feeds
- Roche Events Podcast
- Subscribe to Roche News
- Follow Roche on Twitter
Upcoming Events
-
January 25, 2012
Media Conference Call Illumina Transaction -
Basel, Switzerland, February 01, 2012
Annual Media Conference